Perron Institute

The Perron Institute is a pillar in the global neuroscience community, celebrating over 40 years of leadership in research. Based in Western Australia, it is the state's first and longest-established medical research institute. With a robust focus on research translation, the institute aims to transform lab discoveries into real-world applications as quickly and safely as possible.

They have a rich history of milestones and achievements, including ground-breaking drugs for Duchenne muscular dystrophy that received accelerated approval from the US FDA. They've also contributed to the discovery of the SOD1 MND gene and identified Inclusion Body Myositis as a clinical entity, among others. Their legacy extends to the honour of their founder, the late Emeritus Professor Byron Kakulas AO, who has been a pioneering figure in the field.

Located at the Ralph and Patricia Sarich Neuroscience Institute, they also host the Neurotrauma Research Program and have made significant contributions to palliative care and stroke research. With their commitment to personalised, precision medicine, the institute stands at the forefront of tackling global health challenges.

1. Movement Disorders Clinic: Specialising in Parkinson's disease, Essential Tremor, and dystonia.
2. Neuroimmunology Conditions: Comprehensive care for Multiple Sclerosis and other conditions.
3. Muscle and Nerve Diseases: Expertise in Inflammatory muscle diseases like Inclusion Body Myositis and polymyositis.
4. Post-Stroke Care: Providing complex post-stroke treatments and rehabilitation.
5. Epilepsy Services: Offering care for refractory epilepsy and epilepsy in pregnancy.
6. Motor Neurone Disease Clinic: Specialised treatments and support.
7. Botulinum Toxin Services: Injection service for movement disorders and spasticity.

1. Neuroimmunology

‍